Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. KRAS testing for metastatic colorectal cancer using therascreen KRAS RGQ PCR kit. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Issues in Emerging Health Technologies. 2014 Authors' conclusions KRAS testing is currently performed in many laboratories in Canada using several different methods with varying accuracy and sensitivity. Indexing Status Subject indexing assigned by CRD MeSH Colorectal Neoplasms; Neoplasm Metastasiss; Polymerase Chain Reaction; Proto-Oncogene Proteins; ras Proteins Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32014000734 Date abstract record published 07/07/2014 |